The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Merck Sharp & Dohme LtdEU/1/07/437/003-004

Main Information

Trade NameIvemend
Active SubstancesFosaprepitant dimeglumine
Dosage FormPowder for solution for infusion
Licence HolderMerck Sharp & Dohme Ltd
Licence NumberEU/1/07/437/003-004

Group Information

ATC CodeA04AD Other antiemetics
A04AD12 aprepitant


License statusAuthorised
Licence Issued31/08/2010
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing Status


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back